---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-040087"
form_type: "8-K"
ticker: null
cik: "0001394319"
company_name: "Tracon Pharmaceuticals, Inc."
filed_at: "2022-12-30T23:59:59+00:00"
generated_at: "2026-06-20T21:23:29.323129+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TRACON receives Nasdaq notice for market value below $35M; 180-day cure period

## Summary
- On Dec 30, 2022, Nasdaq notified TRACON that its common stock market value was below $35M for 30 consecutive business days.
- Company has until June 28, 2023 to regain compliance by having market value >=$35M for 10 consecutive business days.
- Alternative compliance: stockholders' equity >=$2.5M or net income from continuing operations of $500,000 in most recent fiscal year.
- Failure may result in delisting; company evaluating potential actions to regain compliance but no assurance.
- TCON continues trading on Nasdaq during grace period.

## SEC filing metadata
- accession: 0001564590-22-040087
- form_type: 8-K
- cik: 0001394319
- company_name: Tracon Pharmaceuticals, Inc.
- filed_at: 2022-12-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1394319/000156459022040087/0001564590-22-040087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1394319/000156459022040087/tcon-8k_20221230.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-040087
- JSON: https://secwatch.observer/filing/0001564590-22-040087.json
- Plain text: https://secwatch.observer/filing/0001564590-22-040087.txt

## Key facts
- Listing & Compliance Notices
  Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2), 5810(c)(3)(C)
  source text: December 30, 2022, TRACON Pharmaceuticals, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the market value of the Company’s common stock was less than $35.0 million, which does not meet the requirement for continued listing on the Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “Market Value Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), Nasdaq has provi
  evidence_url: https://www.sec.gov/Archives/edgar/data/1394319/000156459022040087/0001564590-22-040087-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.